0
    0
    Your Cart
    Free delivery remains: 39.00 
    39 
    Free delivery
    Your cart is empty.Return to the shop
      Calculate shipping costs

      The ANSM classifies HHC as "a synthetic drug with a risk of addiction"

      The French National Agency for Medicines and Health Products Safety (ANSM) recently classified HHC, a cannabis derivative, as a "synthetic drug with a risk of addiction." In the context of increasingly heated debates surrounding the legalization and regulation of cannabis and its derivatives, this announcement is likely to cause a stir.

      ANSM and HHC

      The HHC in question

      HHC, or hexahydrocannabinol, is a chemical derived from cannabis. Due to its molecular structure, it can mimic some of the effects of THC, the main psychoactive component of cannabis. However, unlike THC, HHC has so far escaped regulation because it is a synthetic compound rather than one that occurs naturally in the cannabis plant.

      HHC has gained popularity as a substitute for those seeking the effects of cannabis without breaking the law. However, the ANSM (French National Agency for Medicines and Health Products Safety) is now warning that this substance could be addictive.

      Coercive measures in view

      The ANSM has promised "very coercive measures" in response to this assessment, although no specific details have been given regarding the nature of these measures. A final decision is expected "in the very next few days.".

      This announcement immediately sparked concerns among users and producers of cannabis. Some fear that these measures could negatively impact the nascent cannabis industry in France, which has already been affected by stricter regulations on cannabis-derived products.

      A debate that remains heated

      The ANSM's statement comes amid intensified debate on the legalization of cannabis and its derivatives. Some advocate for stricter regulation to protect public health, while others believe that legalization and regulation could help control product quality and reduce the black market.

      In this context, the ANSM announcement raises questions about how France chooses to regulate cannabis derivatives and the impact this could have on the industry and users.

      Pending the ANSM's final decision, the future of HHC in France remains uncertain. The coming days will be crucial for the HHC industry and for those who use this product as a substitute for cannabis.

      Hello everyone! I'm Daniel from Lord Of CBD. Passionate about cannabis since childhood, I write articles about the world of cannabinoids in France and abroad. With a degree in digital marketing and finance, I bring a fresh perspective to the world of CBD. I joined the lordofcbd.fr team in 2021 as an expert and regular contributor. Thanks to my scientific expertise and clear writing style, I help demystify the various complex aspects of the CBD world, while highlighting its benefits and potential applications through articles and participation in conferences such as the UPCBD. You can find my contributions and interviews in our dedicated articles, as well as in international publications like Challenges.fr, LePoint.fr, and Actu78.fr.
      SPIN TO WIN! Try your luck once a week!
      • Try your luck to get a discount coupon
      • One round per email every week!
      • No cheating
      I'll give it a shot!
      Never
      Call back later
      No thanks